Comparing treatment schedules for liver scarring from schistosomiasis
Part of Digestive system, Infections clinical trials.
This trial tests two different schedules of the drug praziquantel to see which works better for treating liver scarring caused by a parasitic infection called schistosomiasis. It aims to improve liver health and prevent complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 15 and 40 years old
- You have a confirmed schistosomiasis infection (a parasite that can cause liver damage) and evidence of liver scarring on ultrasound
- You are generally healthy apart from the liver issues caused by this infection
- You are not pregnant
- You can provide consent (or have a parent/guardian provide consent if you are under 18)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how active a long-term schistosomiasis infection is in travelers and migrants. It aims to better understand the infection to help guide treatment.
This study tests a new medicine called arpraziquantel to treat schistosomiasis (a disease from parasites in water) in young children aged 2 to 5. It aims to see if giving this treatment in communities where the disease is common is safe and helpful.
This study aims to identify the types of schistosomiasis (a parasitic infection) in patients in Assiut Governorate. It involves testing urine or stool samples to confirm the infection.
This study tests whether a new drug called AZD2389 is safe and well-tolerated in adults with steatotic liver disease (fatty liver) that has progressed to advanced scarring. The trial aims to see if this drug might help slow or improve liver damage in people with this condition.
This study tests whether giving preventive medicine to people who move or migrate can help control river blindness and lymphatic filariasis. It focuses on children and household heads who have missed past treatment rounds.
This study looks at how well the right side of the heart works with the lungs in people who have a lung condition caused by schistosomiasis (a parasitic infection). It uses an ultrasound of the heart to check this connection. Results may help doctors understand and treat this condition better.
Hear when a new Schistosomiasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.